Nathan L. Alderson
- Clinical Biochemistry top 0.1%
- Molecular Biology top 10%
- Physiology top 2%
- Endocrinology, Diabetes and Metabolism top 1%
- Cell Biology top 2%
- Co-authors
- Suzanne R. ThorpeJohn BaynesJ. Larry DurstineMichael A. FergusonHiroko HamaR. WelshPaul G. DavisJohn M. Davis
- Topics
- Advanced Glycation End Products research (14 papers)Muscle metabolism and nutrition (9 papers)Natural Antidiabetic Agents Studies (8 papers)
- Journals
- Journal of Biological ChemistryAmerican Journal of Clinical NutritionJournal of Applied Physiology
- Partner nations
- United StatesAustraliaGermany
In The Last Decade
Nathan L. Alderson
39 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Clinical Biochemistry 1.2k
- Molecular Biology 1.1k
- Physiology 1.1k
- Endocrinology, Diabetes and Metabolism 804
- Cell Biology 464
Countries citing papers authored by Nathan L. Alderson
This map shows the geographic impact of Nathan L. Alderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan L. Alderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan L. Alderson more than expected).
Fields of papers citing papers by Nathan L. Alderson
This network shows the impact of papers produced by Nathan L. Alderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan L. Alderson. The network helps show where Nathan L. Alderson may publish in the future.
Co-authorship network of co-authors of Nathan L. Alderson
This figure shows the co-authorship network connecting the top 25 collaborators of Nathan L. Alderson. A scholar is included among the top collaborators of Nathan L. Alderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan L. Alderson. Nathan L. Alderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 24 | |
| 2 | 30 | |
| 3 | 203 | |
| 4 | 58 | |
| 5 | 46 | |
| 6 | 153 | |
| 7 | 23 | |
| 8 | 11 | |
| 9 | Simple non-invasive assessment of advanced glycation endproduct accumulationbreakdown → | 585 |
| 10 | 56 | |
| 11 | 13 | |
| 12 | 152 | |
| 13 | 149 | |
| 14 | 102 | |
| 15 | 315 | |
| 16 | 442 | |
| 17 | 101 | |
| 18 | 187 | |
| 19 | 76 | |
| 20 | 2 |
About Nathan L. Alderson
Nathan L. Alderson is a scholar working on Clinical Biochemistry, Biochemistry and Cell Biology, having authored 39 papers that have together received 4.0k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (14 papers), Muscle metabolism and nutrition (9 papers) and Natural Antidiabetic Agents Studies (8 papers). The work is most often cited by research in Clinical Biochemistry (1.2k citations), Aging (212 citations) and Endocrinology, Diabetes and Metabolism (804 citations). Nathan L. Alderson has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Suzanne R. Thorpe, John Baynes, J. Larry Durstine, Michael A. Ferguson, Hiroko Hama, R. Welsh, Paul G. Davis, John M. Davis, Thomas Metz and Peter W. Grandjean. Their work appears in journals such as Journal of Biological Chemistry, American Journal of Clinical Nutrition and Journal of Applied Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.